CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4 enrolled
Drug / intervention
VATS resection of MEPAprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05696405
NCT05696405N/ACompleted

Thoracoscopic Treatment of Mediastinal Ectopic Parathyroid Adenomas: A Case Series and Literature Review

Hospital General Ajusco Medio·observational·Posted Jan 25, 2023·Updated Jan 25, 2023

In Brief

An observational study evaluating VATS resection of MEPA for Mediastinal Parathyroid Adenoma and Hyperparathyroidism. Completed, enrolled 4 participants.

Detailed Summary

Background: hyperparathyroidism (HPT) is a disease caused by hypersecretion of one or more parathyroid glands, it can be associated with ectopic mediastinal parathyroid glands (MEPA) in 2% of cases. The use of video-assisted thoracoscopic surgery (VATS) for the surgical resection of these glands is a safe, cost-effective, and low-morbidity option for patients with MEPA. We report a case series of patients with this disease managed with VATS. Patients \& Methods: From 2008 to 2022, a retrospective study involving patients with MEPA and treated by VATS approach was performed in a tertiary hospital in Mexico City. Relevant biochemical and clinical variables such as imaging studies, pre and postoperative lab results, surgical strategy and outcomes, and pathological analyses were analyzed.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 25, 2023
Enrollment StartJan 1, 2008
Primary CompletionJan 1, 2022
TodayJul 2, 2026
Enrollment to primary: 14 yearsPosted 3.4 years ago

Interventions

VATS resection of MEPAprocedure

VATS resection of mediastinal parathyroid adenoma